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Abstract 
In this paper, hybrid QM/MM molecular dynamics (MD) simulations have been 
performed to explore the mechanisms of hydrolysis of two antibiotics, Imipenen (IMI), 
an antibiotic belonging to the subgroup of carbapenems, and the Cefotaxime (CEF), a 
third-generation cephalosporin antibiotic, in the active site of a mono-nuclear β-
lactamase, CphA from Aeromonas hydrophila. According to our results, significant 
different transition state structures are obtained for the hydrolysis of both antibiotics: 
while the TS of the CEF is a ionic species with negative charge on nitrogen, the IMI TS 
presents a tetrahedral-like character with negative charge on oxygen atom of the 
carbonyl group of the lactam ring. Thus, dramatic conformational changes can take 
place in the cavity of CphA to accommodate different substrates, which would be the 
origin of its substrate promiscuity. This feature of the β-lactamase would be in turn, 
associated to the different mechanisms that the protein employs to hydrolyze the 
different antibiotics; i.e. the catalytic promiscuity. Since CphA shows only activity 
against carbapenem antibiotic, this study will be used to shed some light into the origin 
of the selectivity of the different MbL and, as a consequence, into the discovery of 
specific and potent MβL inhibitors against a broad spectrum of bacterial pathogens.   
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Introduction 
β-lactam antibiotics are the most effective chemotherapeutic agents for the treatment of 
bacterial infections, accounting for more than half of the world’s antibiotic market.1,2 
The mechanism of the antibacterial activity of β-lactames involves the inhibition of the 
biosynthesis of the bacterial cell wall peptidoglycan. Nevertheless, despite much 
progress in antibiotics design has been done during the past decades, the increasing use 
of these compounds has induced the development of different resistance mechanisms in 
pathogenic microorganisms.1 One strategy developed by bacteria to resist the action of 
antibiotics is the expression of β-lactamases3 that hydrolyse the four-membered ring of 
β-lactam antibiotics. It is accepted that hydrolysis involves nucleophilic attack on the 
carbonyl group of the β-lactam ring and protonation of N atom with concomitant 
scission of the carbon-nitrogen bond. Nevertheless, there is still a question of debate on 
the timing of carbon-nitrogen scission bond and the protonation of the N, which could 
even take place concertedly. A detailed knowledge of the hydrolysis of the four-
membered ring of β-lactam antibiotics reaction mechanism is required in order to know 
the possible ways of inhibiting bacteria activity. Nevertheless, this is not an easy task 
due to the plethora of different β-lactamases identified up to now. Today, more than 500 
β-lactamases are known, classified into four groups,4 A-D, according to their amino acid 
sequence.5 Groups A, C and D, also called serine-β-lactamases (SβLs), utilize an active 
site serine as a nucleophile,1 while B group, or metallo-β-lactamases (MβLs), required 1 
or 2 Zn(II) ions to perform the hydrolysis. 
The MβLs family was defined in 1997 as a new superfamily of metallohydrolases.6 
There has been a growing concern on this zinc-dependent β-lactamases since, despite 
catalyzing the same reaction, it seems that SβLs and MβLs do not share any structural 
nor mechanistic similarity7 and, in fact, the latter are unaffected by all clinically useful 
inhibitors of the serine-active enzymes.8 In fact, no MβL inhibitors are available for 
clinical use.9 
Three subgroups of MβL have been further identified depending on sequence structure 
and activity similarities. B1 and B3 subclasses posses a binuclear active site, which 
requires one or two Zn(II) ions for full activity and are able to hydrolyze carbapenems, 
pelicinillins and cephalosporins.9 B2 subclass, unlike those from subclasses B1 and B3, 
are fully active with one zinc ion bound and possess a narrow spectrum of activity, 
hydrolyzing carbapenem substrates almost exclusively.10 Initially, a reduced number of 
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structures of B2 MβL, CphA from Aeromonas hydrophila,11 ImiS from Aeromonas 
veronii bv. Sobria12 and Sfh-I from Serratia fonticola,10 have been cristalyzed, being the 
CphA the most studied one. In particular, three different structures, two of them in the 
apo form and the last one corresponding to the N220G mutant in complex with a 
biapenem (Bia) derivative, were obtained. Nevertheless, there are some concerns related 
with these structures. As commented by Garau et al., the electron density could not be 
interpreted as either biapenem or a hydrolyzed biapenem molecule, although it was 
clear the presence of two fused rings near the zinc ion and both, C2 and C3 carbon 
atoms of the intermediate exhibiting sp3 hybridization.11 Then, it appears that the 
molecule has lost the double bond established between these two atoms. Consequently, 
it is difficult to associate this complex to an intermediate or a product of the antibiotic 
hydrolysis, as suggested by experimental studies of Sharma et al. for the reaction 
catalyzed by ImiS.12 The CphA-Bia complex structure has shown how the zinc metal 
accommodates in the Zn2 site, with a trigonal bipyramidal coordination formed by 
Asp120, Cys221, His263, the carboxylate oxygen and the N4 atoms of Bia. Based on 
these X-ray structures, Garau et al. suggested a mechanism involving a non-metal-
binding water nucleophile, activated by His118, that would attack the carbonyl carbon 
of the substrate, leading to cleavage of the C7-N4 bond of the lactam ring. This proposal 
has been supported by theoretical calculations of Xu et al.13,14 although suggesting that 
Asp120 would be the base activating the water molecule, instead of His118. In a more 
recent paper, Wu et al. 15 proposed a complete reaction mechanism for the hydrolysis of 
biapenem antibiotic catalyzed by CphA, arguing that the CphA-Bia complex determined 
by Garau et al. would belong to a minor pathway, in contrast to the original suggestion. 
In this regard, simulations performed by Gatti 16 suggest that the bicyclic derivative of 
Garau et al. would not be formed inside the enzyme active site. Hydrolyzed biapenem 
might be released first, cyclization would occur in solution and then the bicyclic 
compound would bind back to the active site. 
An alternative mechanism was proposed by Simona et al 17,18 where the nucleophilic 
attack and the proton transfer to the nitrogen atom of the lactam ring would occur in a 
single concerted step. According to this proposal, the mechanism requires the activation 
of a second catalytic water molecule in the active site of the enzyme. This mechanism 
would be in agreement with experimental studies of Sharma et al 12 based on proton 
inventories showing that at least one proton transfer must be involved in the rate 
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limiting step. Nevertheless, the proposal is based on the existence of a conformation of 
the Michaelis complex in which the substrate binds the zinc metal through a water 
molecule. This model is not confirmed by the structural studies of Crowder et al.19 
based on enzyme-product complexes, that suggest a direct contact between the zinc 
metal and the carboxylate of the substrate. An initial structure presenting this direct 
contact was used by Xu et al.13-15 to propose a step-wise mechanism that renders an 
estimated free energy barrier for the nucleophilic attack of ca. 14 kcal·mol-1,13 a value in 
very good agreement with the kinetic experiments of Garau et al.11 Nevertheless, this 
comparison requires the hypothesis that such step was the rate limiting step of the 
enzymatic cycle, apparently in contradiction with the proton inventory experiments of 
Crowder et al.19 and with QM/MM computationally exploration of the full mechanism 
performed by Simona et al.17 In particular, the second step related with the proton 
transfer from Asp120 and Nitrogen atom of substrate, would become the rate limiting 
step, with a total free energy barrier of ca. 24 kcal·mol-1.  
Similar debate was open on the mechanisms of binuclear B1 and B3 beta-lactamases. 
Thus, Dal Peraro et al.20 proposed a mechanism with nucleophilic attack and proton 
transfer taking place in a concerted manner, while the simulations of Xu et al.21 suggest 
that the reaction would be essentially stepwise, with a first rate limiting nucleophilic 
attack leading to an intermediate where the negative charge developed in the nitrogen 
leaving group would be stabilized by one of the Zn metal atoms (Zn2). This stable 
anionic intermediate, experimentally reported by Benkovic and co-workers 22 and by 
Vila and co-workers23, implies a non-negligible energy barrier for the following step. 
Again, the studies of Dal Peraro et al, on B1 metallo beta-lactamases assumed an initial 
structure with the carboxylate of the substrate interacting with the zinc ions through a 
water molecule. This assumption could be in contradiction with reported X-ray 
crystallographic structures of the enzyme complex with the hydrolysis product of an 
antibiotic carried out by Spencer et al. that suggests a direct substrate-metal interaction 
also in reactant complex.24 
Interestingly, β-lactamase catalytic activity has been also studied on B1 class with only 
one zinc metal in the catalytic pocket based on models with the zinc placed in position 
1. 20,25,26 The activity of B1 enzymes in their mono-nuclear form has been measured for 
the hydrolysis of penicillin G catalyzed by Co(II) substitude B1 metallo-β-lactamase, 
BcII.27 According to this study, the metal was observed in both positions, 1 and 2. 
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Furthermore, a biochemical and biophysical characterization of a B3 class of MbL, 
GOB-18, has also revealed catalytic activity for the mono-nuclear enzyme form with the 
zinc ion in position 2. 
In a previous paper, we carried out a computational study to explore the hydrolysis of 
one antibiotic, Cefotaxime (CEF), in gas phase and in aqueous solution by means of 
QM/MM potentials.28 PM3 semiempirical methods rendered results in qualitative 
agreement with DFT calculations with B3LYP and M06-2X hybrid functionals. The 
free energy profiles in solution showed a step-wise mechanism kinetically determined 
by the nucleophilic attack of a water molecule activated by the proton transfer to the 
carboxylate group of the substrate (the first step). According the barrier obtained from 
the second intermediate to products, population of the second intermediate would be in 
agreement with experimentally detected anionic intermediates in β-lactamases.22,23 A 
concerted mechanism, with a water molecule activated by the nitrogen atom of the 
substrate was also obtained although with a much higher free energy barrier. Keeping in 
mind the hypothesis that similar molecular mechanisms take place in solution and in the 
active site of enzymes,29 we are in this paper exploring these two mechanisms in the 
active site of a mono- nuclear β-lactamase. In particular, we are studying the hydrolysis 
of Imipenen (IMI), an antibiotic belonging to the subgroup of carbapenems, and the 
Cefotaxime (CEF), a third-generation cephalosporin antibiotic, in the active site of 
CphA from Aeromonas hydrophila (see scheme 1). Keeping in mind that CphA show 
only activity against carbapenem antibiotic, a comparative analysis of the results 
obtained for both inhibitors will be used to shed some light into the origin of the 
selectivity of the different MbL.  
  
 (a) (b) 
Scheme 1. Schematic representation of (a) Imipenen, IMI, and (b) Cefotaxime, CEF, β-lactam antibiotics.  
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Computational Methods 
The initial coordinates were taken from the 1.90 Å resolution X-ray crystal structure of 
a mutated CphA from Aeromonas hydrophila complexed with the hydrolysed biapenem 
(BMH) antibiotic (PDB entry 1X8I).11 IMI and CEF were docked on position initially 
occupied by BMH. Hydrogen atoms were incorporated into the structure to a state 
complementary to pH 7.5, using fDYNAMO library.30 Since standard pKa values of 
ionizable groups can be shifted by local protein environments31,32, an accurate 
assignment of the protonation states of all these residues was carried out by 
recalculating de standard pKa values of the titratable amino acids with the empirical 
PROPKA3.33 The residues which have a different pKa from the standard values in 
solution were: Cys221 unprotonated (with charge of -1); Lys224 defined as neutral; and 
Glu68 that was defined as protonated. Histidines residues have been protonated as 
follow: His96 and His263 protonated in Nδ; His 118 and His196 protonated in Nε; and 
His176, His268 and His275 protonated in both N (Nδ and Nε) with a charge of +1. Due 
to the fact that the total charge of the system was not neutral, four Cl- counterions were 
placed in optimal electrostatic positions around the protein (never closer than 10.5 Å 
from any atom of the system or 5 Å from another counterion, and using a regular grid of 
0.5 Å). Then the system was placed in the mass centre of a cavity deleted from a 
prerelaxed orthorhombic box of water molecules (80 x 80 x 100 Å3). All the water 
molecules with an oxygen atom lying within 2.8 Å of any heavy atom were removed.  
The entire chemical system was then divided into a QM region described by means of 
PM334,35 semiempirical method (using zinc parameters optimized for 
metalloenzymes36), and a MM region described with the OPLS-AA and TIP3P37 force 
fields for the protein and water molecules, respectively. The QM region comprised the 
substrate, the Zinc atom, the side chains of Asn116, His118, Asp120, His196, Cys221 
and His 263, and the water molecules that were required for the hydrolysis. The MM 
region contains the rest of the system, including counterions and crystallization and 
solvation water molecules. Then, the full system contains 94 QM atoms in the system 
with IMI and 104 QM atoms in the system with CEF (see Scheme 2). The link-atom 
method38 was used to treat the covalent bonds of amino acids crossing the boundary 
between the QM and MM regions, between the cα and cβ atoms, to satisfy the valence of 
the QM fragments.  
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Scheme 2. QM region in the different calculation with Imipenen (IMI in blue) and Cefotaxime (CEF in 
red), link atoms are represented by black dots.  
All atoms away from a sphere of 30 Å radius centered in the substrate, were kept frozen 
during all simulations. For this purpose, a Langevin bath with a coupling temperature of 
300 K was employed throughout this work, using the canonical thermodynamic 
ensemble (NVT). A total run of 200 ps for the whole system was made with an 
integration step size of 1 fs. Periodic boundary conditions (PBC) and a switch function 
of a cutoff distance in the range of 14.5–18 Å were used to treat the nonbonding 
interactions. After setting up the model, the complete system was optimized using the 
Adopted Basis Newton Raphson (ABNR) method with the backbone of the protein 
frozen, and then equilibrated it by 500 ps QM/MM MD simulation.39 The last structure 
from this 500 ps MD simulation was fully optimized again to serve as the reaction 
reactant for the rest of the study. QM/MM Potential Energy Surfaces, PESs, for the four 
systems have been computed to explore different mechanisms, and stationary point 
structures characterized by frequency calculations were located. Afterwards, the free 
energy profiles of the possible reaction paths were obtained in terms of two-dimensional 
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potential of mean force, 2D PMFs, computed as a function of distinguished geometrical 
reaction coordinates (RC) deduced from the PESs explorations. In particular, the 
mechanism found was a concerted mechanism, in particular two RC were chosen, the 
distance of the nucleophilic attack RC1: d(OH2-C) and the antisymmetric combination 
of the distances involved in the Nitrogen protonation RC2: d(OH2-H2)-d(H2-N). 
The weighted histogram analysis method (WHAM), combined with the umbrella 
sampling approach,40,41 was employed to scan the reaction coordinates. Umbrella force 
constant of 2800 KJ·mol-1·Å-2, were applied to the distinguished reaction coordinates to 
allow a perfect overlapping among the windows. 10 ps of relaxation and 20 ps of 
production, with a time step of 0.5 fs using the velocity Verlet algorithm42 to update the 
velocities, were run in each window. The PMFs were performed at 300 K, using the 
NVT ensemble. Structures from the previously obtained QM/MM PESs were used as 
starting points of each window.  
The activation free energy for a particular reaction can be evaluated from the difference 
in the value of the one dimensional PMF between the maximum (the transition state) 
and the minimum (the reactants state). The activation free energy can be then recovered 
from the 2D-PMF tracing a maximum probability reaction path on the 2D-PMF surface 
and integrating over the perpendicular coordinate. 43  
Because of the large number of structures that must be evaluated during free energy 
calculations, QM/MM calculations are usually restricted to the use of semiempirical 
Hamiltonians. In order to reduce the errors associated to the quantum level of theory 
employed in our simulations, a new energy function defined in terms of interpolated 
corrections was used:44-46 
E = EAM1/MM +S ΔELLHL (ζ1,ζ2 )"# $%  (1) 
where S denotes a two-dimensional spline function, and its argument ),(E 21
HL
LL ζζΔ is a 
correction term evaluated from the single-point energy difference between a high-level 
(HL) and a low-level (LL) calculation of the QM subsystem. PM3 semiempirical 
Hamiltonian was used as LL method while a density functional theory (DFT)47 
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method was selected for the HL energy calculation. In particular, HL energy 
calculations were performed by means of the hybrid M06-2X48 functional using the 
standard 6-31+G* basis set. These calculations were carried out using the Gaussian09 
program.49  
11 
Results 
The reaction paths corresponding to the concerted and the step-wise mechanism, 
equivalent to the mechanisms previously explored in aqueous solution in our lab,28 have 
been explored by QM/MM PESs. The results show that any attempts to get the PESs 
corresponding to a step-wise mechanism, describing a proton transfer from a water 
molecule to the oxygen atom of the carboxylate group of the substrate and the 
nucleophilic attack to the carbonyl carbon of the beta-lactam ring, was unsuccessfully. 
Obviously, the fact that the carboxylate group is strongly interacting with the Zn ion 
rules out the possibility of acting as a proton acceptor. The PESs of the concerted 
mechanism corresponding to the hydrolysis of IMI and CEF are presented in Figure 1. 
The antisymmetric combination of Ow1Hw1— Hw1N4 distances and the Ow1— C7 
distances were employed to generate the PESs. 
   
 (a) (b) 
Figure 1. QM/MM PES of hydrolysis of (a) IMI and (b) CEF antibiotics performed in the active site of 
the CphA from Aeromonas hydrophila.  
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the proton transfer. IRC paths were traced down from these TSs forward and backwards 
to the corresponding reactants and products valleys. Finally, fully optimizations were 
carried out to reach the minimum energy structures, confirming the located TSs connect 
the reactants and products. Key distances of structures of the active site in reactants, 
transition states and products are listed in Table S1 of Supporting Information, for 
hydrolysis of IMI and CEF, respectively. 
Once the PESs were explored, the free energy surfaces, obtained in terms of 2D PMFs, 
were computed and the results are presented in Figure 2. Averaged values of key inter-
atomic distances obtained in reactants, TS and products of hydrolysis of both antibiotics 
are listed in Table 1, schematic representation of these states are presented in Figures 3 
and 4, and values of relative energies deduced from the QM/MM 2D PMF and from the 
PESs, both activation and reaction energies, are listed in Table 2. The free energy 
surfaces presented in Figure 2 are in a qualitative agreement with the corresponding 
PESs presented in Figure 1. The minimum free energy profile describes a mechanism 
where the nucleophilic attack of the water molecule to C7 atom and the proton transfer 
to the N atom of the beta-lactam ring take place in a concerted way. In both cases, once 
the TS is reached the process is controlled basically by the coordinate associated to the 
proton transfer.  
 
 (a) (b) 
Figure 2. QM/MM 2D PMF of hydrolysis of (a) IMI and (b) CEF antibiotics performed in the 
active site of the CphA from Aeromonas hydrophila. 
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 Reactant 
TS 
 Product 
Figure 3. Schematic representation of located structures of reactants, TS and products of the hydrolysis of 
IMI antibiotics catalysed by the N220G CphA from Aeromonas hydrophila. 
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Reactant 
TS 
Product 
Figure 4. Schematic representation of located structures of reactants, TS and products of the hydrolysis of 
CEF antibiotics catalysed by the N220G CphA from Aeromonas hydrophila.  
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As observed in Figure 3, the reactants structure of IMI hydrolysis shows how the Zn 
appears coordinated to His263, to Asp120 (bifurcated coordination), to a water 
molecule w2, and to the antibiotic through the carbonyl oxygen and the carboxylate 
group. The carbonyl bond of IMI seems to be polarized by the water molecule w2 and 
by the Zn atom, thus activating the C7 atom of the lactam ring for the nucleophilic 
attack. Another role of w2 molecule is to participate in an indirect coordination between 
Cys221 and the Zn atom. The reactive water molecule, w1, appears to be oriented by the 
interaction with Asp120 for the nucleophilic attack to C7. As the reaction proceeds, the 
w1 molecule approach to the antibiotic and its interaction with Asp120 is lost after 
reaching the TS. Asp120 interaction with Zn cation does not change during the full 
process. Nevertheless, while a perfectly symmetric bifurcated interaction is established 
in reactants and TS of IMI, the Zn ion is preferentially interacting with only one oxygen 
atom of the Asp120 in products. According to the average values obtained from the 
structures derived from the 2D PMF, Asp120 would not follow the displacement of the 
w1 nucleophilic water molecule during the process in IMI hydrolysis. In fact, the 
shortest distance between oxygen atom of Asp120 and the hydrogen atom of w1 is 
observed in the TS (1.77 Å) while this distance is significatively larger in products (2.61 
Å). 
Structures for the hydrolysis of CEF (see Fig. 4) are significantly different. First of all 
Zn metal presents a tetrahedral coordination, interacting with the carboxylate group of 
the antibiotic, His263, Cys221 and Asp120. Interestingly, interaction of Asp120 and Zn 
ion in this system takes place through a single interaction that does not change during 
the process (from 1.95 to 2.00 Å). The nucleophilic water molecule w1, is interacting 
with His118 that orients the molecule for the attack, and not with Asp120 as in the IMI 
hydrolysis. This w1 water molecule is activated by an interaction with the carboxylate 
group of the substrate through a water molecule w2. Finally, it is also noticeable the 
interaction between His118 and Asp120 through a conserved water molecule w3. This 
interaction, as well as the coordination sphere of the Zn atom does not change along the 
reaction process from reactants to products, as appeared in the IMI hydrolysis reaction. 
A detailed analysis of evolution of C7-O distance, as reported in Table 1, shows how 
the TS in IMI presents a tetrahedral coordination of the C7 carbon atom of the beta 
lactam ring (1.29 Å), not observed in reactants or products, where the distance is 
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significantly shorter (1.22 and 1.24 Å, respectively), characteristic of a double bond 
with a planar conformation. The oxygen atom is basically stabilized by an oxyanion 
hole through interaction with Zn ion (2.03 Å). The interaction of the carbonyl oxygen 
established in reactants with the w2 water molecule is stronger than in TS and products, 
as shown by a shorter interatomic distance (1.79 Å in reactants and 2.40 and 2.43 Å in 
TS and products, respectively). In CEF hydrolysis, no interaction is observed between O 
and Zn ion, which is related with the almost unchanged value of C7-O distances during 
the reaction. The value of the obtained C7-O distance in the three states is characteristic 
of a double bond (1.20, 1.20 and 1.22 Å in R, TS and products, respectively). These 
differences are related with the differences observed in the N4-C7 distance. A large 
value of this distance is observed in the TS of the CEF (2.69 Å) while the value 
obtained in the IMI TS (1.57 Å) reveals a completely different nature of the TSs. 
Analysis of the distances describing the position of the transferred proton from the 
reactive w1 water molecule to N4 atom of the beta-lactam ring shows how the TS of the 
hydrolysis of IMI is more dissociative than the TS of CEF hydrolysis. Thus, the 
distances between the transferred proton and the donor and acceptor atoms obtained in 
IMI (1.31 and 1.43 Å, respectively) are significantly larger than the values obtained in 
CEF (1.12 Å and 1.39 Å, respectively). These differences of the TS located for the IMI 
and CEF hydrolysis indicate CphA, depending on the antibiotic, can use different 
mechanisms. 
Population analysis on reactants and TS in both reactions (see Table S2 of Supporting 
Information) confirms the difference nature of the TSs. The results show how the charge 
in N4 and carbonyl O atom of the beta-lactam ring are increased by -0.31 a.u. and -0.01 
a.u. when going from reactants to TS in the CEF. This trend is completely different in 
IMI; where the charge on N1 atom is virtually unchanged (from -0.007 to +0.007 a.u.), 
O atom charge changes from -0.286 to -0.568 a.u. in the TS. As summary, negative 
charge was located in the O atom of the carbonyl group in the TS of the IMI hydrolysis, 
while in the CEF the charge is mostly in the N4 atom. This electronic analysis confirms 
the geometrical analysis and reveals two different mechanisms. 
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Table 1. Key interatomic distances obtained from the MD simulations performed at reactants, TS and 
products of the hydrolysis of (a) IMI and (b) CEF antibiotics performed in the active site of the N220G 
CphA from Aeromonas hydrophila obtained at PM3/MM level. All values are reported in Å.  
 IMI CEF 
 R TS P R TS P 
d(C7,Ow) 4.25 ± 0.24 1.47 ± 0.00 1.33 ± 0.02 3.65 ± 0.34 1.46 ± 0.00 1.35 ± 0.02 
d(Ow,Hw) 0.96 ± 0.02 1.31 ± 0.00 2.84 ± 0.23 0.95 ± 0.02 1.12 ± 0.00 3.38 ± 0.47 
d(Hw,N4) 4.43 ± 0.29 1.43 ± 0.00 1.00 ± 0.03 4.12 ± 0.51 1.39 ± 0.00 1.00 ± 0.03 
d(C7,N4) 1.46 ± 0.03 1.57 ± 0.00 2.82 ± 0.08 1.47 ± 0.03 2.69 ± 0.00 2.73 ± 0.12 
d(O,C7) 1.22 ± 0.02 1.29 ± 0.02 1.24 ± 0.02 1.20 ± 0.02 1.20 ± 0.02 1.22 ± 0.02 
d(Zn, O) 2.05 ± 0.05 2.03 ± 0.04 2.04 ± 0.05    
d(Zn, O9) 1.97 ± 0.03 1.97 ± 0.03 1.97 ± 0.03 1.94 ± 0.03 1.94 ± 0.03 1.96 ± 0.03 
d(Zn, Asp120-O1) 2.06 ± 0.05 2.07 ± 0.05 2.26 ± 0.41 1.95 ± 0.03 1.95 ±  0.03 2.00 ± 0.05 
d(Zn, Asp120-O2) 2.07 ± 0.05 2.08 ± 0.05 2.04 ± 0.05    
d(Zn, His263) 2.07 ± 0.04 2.06 ± 0.04 2.07 ± 0.05 2.04 ± 0.04 2.03 ± 0.04 2.07 ± 0.05 
d(Zn, Ow2) 2.06 ± 0.05 2.05 ± 0.04 2.05 ± 0.05    
d(O,Hw2) 1.79 ± 0.11 2.40 ± 0.52 2.43 ± 0.61    
d(Asp120,H2w1) 2.33 ± 0.53 1.77 ± 0.06 2.61 ± 0.54    
d(Zn, Cys221)    2.37 ± 0.08 2.34 ± 0.08 2.45 ± 0.12 
d(Hw2-O10)    2.72 ± 0.64 2.04 ± 0.24 2.53 ± 0.53 
 
 
Table 2. Reaction and activation energies obtained in terms of potential energies (ΔE‡ and ΔER) and free 
energies (ΔG‡ and ΔGR), for the hydrolysis of IMI and CEF antibiotics performed in the active site of the 
N220G CphA from Aeromonas hydrophila obtained at PM3/MM and after correction at M06-2X/MM 
level (ΔG‡ corr and ΔGR corr). All values in kcal·mol-1. 
 ΔE‡ ΔER ΔG‡ ΔGR ΔG‡ corr ΔGR corr 
IMI 45.5 -9.2 39.2  -6.2 32.6 -9.8 
CEF 53.1 -12.9 39.9  -11.2 35.6 -17.5 
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The reaction and activation energies obtained in terms of potential energies (ΔE‡ and 
ΔER) and free energies (ΔG‡ and ΔGR), for the hydrolysis of IMI and CEF antibiotics 
performed in the active site of the N220G CphA from Aeromonas hydrophila obtained 
at PM3/MM level are reported in Table 2. As observed, both potential energy barriers 
are quite high, being the reaction of the IMI hydrolysis clearly more favorable (45.5 vs 
53.1 kcal·mol-1). Nevertheless, both barriers become almost equivalent when computing 
the free energy barriers at the same level of theory (39.2 and 39.9 kcal·mol-1, 
respectively). Thus, a significant reduction in the barriers is observed after including the 
entropic contribution, more dramatic in the case of the CEF hydrolysis. These values, 
when including the correction at M06-2X/MM level, are 32.6 and 35.6 kcal/mol-1. 
Discussion 
Michaelis complex (MC). First conclusion that can be derived from comparison of 
averaged structures of MC of the hydrolysis reaction of CEF and IMI, with the 
experimental X-ray diffraction structure is that both MC structures are quite different 
(see Figure 5). As observed, the structure of CEF in the Michalis complex is similar to 
the holo-enzyme X-ray structure obtained by Garau et al.11 The structure of protein 
complexed with the bis substrate solved by Garau et al., that do not correspond to the 
reactants; neither an intermediate, is comparable with the structure of MC of CEF 
obtained after the MD simulations. Also, the experimental results of Garau et al. suggest 
that the nucleophilic water molecule would be activated by interaction with the His196 
residue, as also indicated by our calculations. On the contrary, the MC obtained for the 
hydrolysis of IMI presents dramatic differences with respect to the experimental 
structures of the apo or the protein-substrate complex determined by Garau. In 
particular, the Asp120 interacts in a bifurcated way with the Zn ion, the carbonyl 
oxygen of the beta lactam ring interacts directly with the Zn ion thus being activated for 
a nucleophilic attack, and finally, a direct interaction between the metal and the Cys221 
is not observed in the structures after our QM/MM MD simulations. 
This discussion can be completed by analysis of Figure 5. This figure shows that while 
the protein backbone of the three structures are almost equivalent, the position of the 
substrate and the metal ions present differences. Thus, the MC structure of the 
hydrolysis of CEF (Fig. 5b) is quite similar to the structure of the protein-bis complex 
deduced from X-ray diffraction methods (Fig. 5a), but the MC structure of the IMI 
hydrolysis (Fig. 5c) is dramatically different. It seems that the Zn ion is displaced in the 
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cavity when the protein is complexed with IMI. Moreover, the antibiotic adopts a 
conformation significantly different to the one observed in the MC of CEF hydrolysis or 
in the X-ray structure of the protein-bis complex. This can be clearly observed when the 
structures are overlapped by the backbone of the proteins (Fig. 5d). These structural 
differences between the MC complexes of IMI and CEF must be related with the 
different mechanisms observed in both systems. Nevertheless, it is important to point 
out that, in both cases, the antibiotic is coordinated to the metal that remains anchored to 
residues such as Asp120 and His263.  
Different coordination modes of metal ion in the active site of metalloenzymes has been 
already observed experimentally by Tawfik and co-workers.50 This plasticity can be 
required for the different steps of the full catalytic cycle or it can also promote catalytic 
promiscuity. In particular, the mechanistic implication of the motion of the zinc ions 
dizinc metallo-beta-lactamases was already observed by Breece et al.51 Thus, keeping in 
mind that the structural experimental evidences are based on the apo enzyme or on a 
complex not corresponding to the reactants or intermediate, none of the obtained 
structures could be, a priori, discarded. 
 
Figure 5. a) X-ray structure of CphA complexed with BMH (PDB entry 1X8I). Representative structures 
of the Michaelis complex of the hydrolysis of CEF (b) and  IMI (c) antibiotics obtained from the 
QM/MM MD simulations. d) Overlapping of structures presented in panels a, b and c. Hydrogen atoms 
have been removed in all panels for clarity purposes. Residues Asp120, Cys221 and His263 have been 
represented by sticks in a, b, and c panels. 
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The problem related with the plasticity of metal ions in the active site of proteins has 
been also discussed in enzymes belonging to the Alkaline Phosphatase superfamily, that 
contains two Zn ions in the active site. Theoretical simulations performed with hybrid 
QM/MM methods, including specific d-orbital description in the semiempirical AM1 
Hamiltonian, was found that movement of Zn ions is dramatic from R to TS.52-55 . 
Nevertheless, we must consider the possibility that, as mentioned by Hou and Cui,56 the 
main cause for the large structural variations in our simulations52-55 was the use of AM1 
to describe the metal ion. The question of whether the large mobility of the metals in 
this kind of enzymes is an artifact of the computing methods or reveals the plasticity of 
the metals in the active site requires further validation to provide a definitive answer, as 
recently proposed in a perspective paper by Kamerlin and co-workers.57 In particular, 
there are no experimental X-ray structures of the Michaelis complex of mono-nuclear 
metallo-beta-lactamases with different substrates to confirm the observations obtained 
in the present paper, where the QM/MM MD simulations have been performed using 
the semiempirical PM3 hamiltonian.  
 
Conclusions 
In this paper, hybrid QM/MM molecular dynamics (MD) simulations have been 
performed to explore the mechanisms of hydrolysis of two antibiotics, IMI (an 
antibiotic belonging to the subgroup of carbapenems) and CEF (a third-generation 
cephalosporin antibiotic), catalyzed by a mono-nuclear β-lactamase, CphA from 
Aeromonas hydrophila. The calculations have allow obtaining, not only the free energy 
profiles that determines the mechanisms and the energetics of the processes, but also a 
deep conformational analysis of the active site. Regarding to the two explored 
mechanism, the hydrolysis of the four-membered ring of β-lactam antibiotics takes 
place through a concerted mechanism where the nucleophilic attack on the carbonyl 
group of the β-lactam ring, the protonation of the N atom and scission of the carbon-
nitrogen bond take place in a single chemical step. Any attempt to obtain the stepwise 
mechanism, which is the most favourable reaction path for hydrolysis of these two 
antibiotics in aqueous solution28 was unsuccessful. A deeper comparative analysis of the 
two reactions in CphA reveals electronically different transition state structures: while 
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the TS of the CEF is a ionic species with negative charge on nitrogen, the IMI TS 
presents a tetrahedral-like character with negative charge on oxygen atom of the 
carbonyl group of the lactam ring. According to our results, dramatic conformational 
changes can take place in the cavity of CphA to accommodate different substrates, 
which would be the origin of its substrate promiscuity. This feature of the β-lactamase 
would be in turn, associated to the different mechanisms that the protein employs to 
hydrolyze the different antibiotics; i.e. the catalytic promiscuity.  
From the energetic point of view, the PMFs obtained at the highest level of theory used 
in the present study, when including the correction at M06-2X/MM level, render free 
energy barriers of 32.6 and 35.6 kcal/mol-1 for the hydrolysis of IMI and CEF, 
respectively. This trend would be in agreement with the fact that CphA shows only 
activity against carbapenem antibiotic. Nevertheless, in our previous study in aqueous 
solution,28 a substrate assisted mechanism presented a barrier of 30.8 kcal·mol-1 at M06-
2X/MM level. Then, although possible, the explored mechanism does not seem to be 
the one taking place in the mono metallo-β-lactamase proteins, considering the obtained 
free energy barriers in both media. Our results suggest that the protein could have a 
chemical role in the catalytic process by favoring the reaction to progress through the 
existence of an intermediate. This is in agreement with a two-step mechanism involving 
participation of a water molecule, as proposed by Simona et al.,18 Asp120 as proposed 
by Wu et al.,15 or His196 as suggested by Garau et al.11 Our results, together with these 
previous studies, demonstrate the complexity of the enzyme reaction mechanisms in 
mono metallo-β-lactamases. In most of the cases, reaction coordinate would involve 
participation of the environment and further more complex explorations of free energy 
surfaces would be required. The complete computational study will then be used to shed 
some light into the origin of the selectivity of the different MβL and, as a consequence, 
into the discovery of specific, potent MβL inhibitors against a broad spectrum of 
bacterial pathogens. 
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